Rise in oil prices creates selling pressure on DAX - Schott Pharma firm after Barclays upgrade - SIXT gains after Berenberg buy study - JOST rises after Buy rating from Warburg - LANXESS under pressure after Exane BNP downgrade - RTX benefits from multi-billion US defense contract!
Reading Time: 6 minutes
The DAX presents itself with more pronounced losses on Tuesday. Pressure on sales is coming from rising oil price quotations, following yet another attack on cargo ships in the Strait of Hormuz yesterday. After a weaker start to trading, the DAX continued to decline and is down by -0.46% at midday. Significant gains are noticeable at the start of trading, especially for Schott Pharma , after Barclays upgraded the stock of the pharmaceutical packaging manufacturer to Overweight and significantly revised its price target upwards. Sixt is also managing...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
